Veracyte Price to Free Cash Flow Ratio 2012-2025 | VCYT

Veracyte price to free cash flow ratio from 2012 to 2025. Price to free cash flow ratio can be defined as

Veracyte Price to Free Cash Flow Ratio 2012-2025 | VCYT

Veracyte price to free cash flow ratio from 2012 to 2025. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$180.2B
Intuitive Surgical (ISRG)$179.4B
Edwards Lifesciences (EW)$47.6B
IDEXX Laboratories (IDXX)$46B
Alcon (ALC)$44B
DexCom (DXCM)$34.9B
IQVIA Holdings (IQV)$32.6B
Mettler-Toledo (MTD)$26.3B
STERIS (STE)$22.6B
Waters (WAT)$17.8B
SONOVA HOLDING (SONVY)$16.4B
Hologic (HOLX)$14.5B
Sysmex ADR (SSMXY)$10.4B
Penumbra (PEN)$9.8B
Masimo (MASI)$8.5B
Globus Medical (GMED)$7.2B
Glaukos (GKOS)$5.4B
Teleflex (TFX)$5B
Integer Holdings (ITGR)$3.8B
TransMedics (TMDX)$3.6B
PROCEPT BioRobotics (PRCT)$2.8B
LivaNova (LIVN)$2.4B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Tandem Diabetes Care (TNDM)$1.1B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$991M